Biofrontera Group

Pharmaceutical Manufacturing • Leverkusen, North Rhine-Westphalia, Germany • 51-100 Employees

Company overview

Headquarters	Hemmelrather Weg 201, Leverkusen, Nordrhein-Westfalen 51377, DE
Phone number	+497814861539
Websites	biofrontera.com bfinc.com
NAICS	3254
SIC	283
Keywords	Dermatology, Photodynamic Therapy, Wirkkosmetik
Founded	1997
Employees	51-100
Socials

Key Contacts at Biofrontera Group

Helge Lubenow

Vice Chair Of The Board Of Directors

Iria González Vasconcellos

European Director Of Medical Affairs | Extended Board Member

Kevin Held

Director Quality Management, Qualified Person

Biofrontera Group Email Formats

Biofrontera Group uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@biofrontera.com), used 54.8% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@biofrontera.com	54.8%
{first name}.{last name}	john.doe@biofrontera.com	41.9%
{first initial}.{second initial}	j.o@biofrontera.com	3.2%

About Biofrontera Group

Biofrontera AG is a biopharmaceutical company specializing in the development and sale of dermatological drugs and medical cosmetics. The Germany-based company develops and markets innovative products for the care, protection and treatment of the skin. The company’s lead product is the combination of Ameluz®, a topical prescription drug, and medical device BF-RhodoLED® for the photodynamic therapy of certain superficial skin cancers and their precursors. Ameluz® has been marketed in the EU since 2012 and in the United States since May 2016. In the EU, the company also sells the dermocosmetics series Belixos®, which offers specialized care for damaged or diseased skin. Biofrontera is the first German pharmaceutical company to receive a centralized European and a US approval for a drug developed in-house. The Biofrontera Group was founded in 1997 and is listed on the Frankfurt Stock Exchange (ticker symbol: B8F) and on the US NASDAQ (ticker symbol: BFRA).

Biofrontera Group revenue & valuation

Annual revenue	$39,200,000
Revenue per employee	$413,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$125,500,000
Total funding	No funding

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Manager

Entry

Head

Employees by Department

Biofrontera Group has 31 employees across 8 departments.

Departments

Number of employees

Funding Data

Biofrontera Group has never raised funding before.

Biofrontera Group Tech Stack

Discover the technologies and tools that power Biofrontera Group's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Usercentrics

Cookie compliance

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

GoDaddy

Hosting

Apple iCloud Mail

Webmail

Slider Revolution

Photo galleries

Slick

JavaScript libraries

PHP

Programming languages

Sectigo

SSL/TLS certificate authorities

TYPO3 CMS

CMS

Bootstrap

UI frameworks

Frequently asked questions

Biofrontera Group is located in Leverkusen, North Rhine-Westphalia, DE.

You can reach Biofrontera Group at +497814861539.

Biofrontera Group was founded in 1997, making it 29 years old. The company has established itself as a significant player in its industry over this time.

Biofrontera Group has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.